Therneau TM - Search Results

1

Glucocorticoids and cardiovascular events in rheumatoid arthritis: a population-based cohort study.

Davis JM 3rd, Maradit Kremers H, Crowson CS, Nicola PJ, Ballman KV, Therneau TM, Roger VL, Gabriel SE. Davis JM 3rd, et al. Among authors: therneau tm. Arthritis Rheum. 2007 Mar;56(3):820-30. doi: 10.1002/art.22418. Arthritis Rheum. 2007. PMID: 17330254 Free article.

2

Prognosis of histological cirrhosis in type 1 autoimmune hepatitis.

Roberts SK, Therneau TM, Czaja AJ. Roberts SK, et al. Among authors: therneau tm. Gastroenterology. 1996 Mar;110(3):848-57. doi: 10.1053/gast.1996.v110.pm8608895. Gastroenterology. 1996. PMID: 8608895

3

Effects of ursodeoxycholic acid on survival in patients with primary biliary cirrhosis.

Lindor KD, Therneau TM, Jorgensen RA, Malinchoc M, Dickson ER. Lindor KD, et al. Among authors: therneau tm. Gastroenterology. 1996 May;110(5):1515-8. doi: 10.1053/gast.1996.v110.pm8613058. Gastroenterology. 1996. PMID: 8613058 Clinical Trial.

4

Optimal timing of liver transplantation for primary biliary cirrhosis.

Kim WR, Wiesner RH, Therneau TM, Poterucha JJ, Porayko MK, Evans RW, Klintmalm GB, Crippin JS, Krom RA, Dickson ER. Kim WR, et al. Among authors: therneau tm. Hepatology. 1998 Jul;28(1):33-8. doi: 10.1002/hep.510280106. Hepatology. 1998. PMID: 9657093

5

Long-term trends in hip fracture prevalence: the influence of hip fracture incidence and survival.

Melton LJ 3rd, Therneau TM, Larson DR. Melton LJ 3rd, et al. Among authors: therneau tm. Osteoporos Int. 1998;8(1):68-74. doi: 10.1007/s001980050050. Osteoporos Int. 1998. PMID: 9692080

6

Long-term survival (10 years or more) in 30 patients with primary amyloidosis.

Kyle RA, Gertz MA, Greipp PR, Witzig TE, Lust JA, Lacy MQ, Therneau TM. Kyle RA, et al. Among authors: therneau tm. Blood. 1999 Feb 1;93(3):1062-6. Blood. 1999. PMID: 9920856 Free article. Review.

7

Incidence of cancer in primary biliary cirrhosis: the Mayo experience.

Nijhawan PK, Therneau TM, Dickson ER, Boynton J, Lindor KD. Nijhawan PK, et al. Among authors: therneau tm. Hepatology. 1999 May;29(5):1396-8. doi: 10.1002/hep.510290511. Hepatology. 1999. PMID: 10216121

8

The relative role of the Child-Pugh classification and the Mayo natural history model in the assessment of survival in patients with primary sclerosing cholangitis.

Kim WR, Poterucha JJ, Wiesner RH, LaRusso NF, Lindor KD, Petz J, Therneau TM, Malinchoc M, Dickson ER. Kim WR, et al. Among authors: therneau tm. Hepatology. 1999 Jun;29(6):1643-8. doi: 10.1002/hep.510290607. Hepatology. 1999. PMID: 10347102

9

Comparison of three doses of ursodeoxycholic acid in the treatment of primary biliary cirrhosis: a randomized trial.

Angulo P, Dickson ER, Therneau TM, Jorgensen RA, Smith C, DeSotel CK, Lange SM, Anderson ML, Mahoney DW, Lindor KD. Angulo P, et al. Among authors: therneau tm. J Hepatol. 1999 May;30(5):830-5. doi: 10.1016/s0168-8278(99)80136-6. J Hepatol. 1999. PMID: 10365809 Clinical Trial.

10

Computing the Cox model for case cohort designs.

Therneau TM, Li H. Therneau TM, et al. Lifetime Data Anal. 1999 Jun;5(2):99-112. doi: 10.1023/a:1009691327335. Lifetime Data Anal. 1999. PMID: 10408179

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results